Diabetes type2 Clinical Trial
Official title:
Proof of Concept Study: Long-term Benefits of a Blend of Nutritional Ingredients for Type 2 Diabetes
This is a prospective randomized, double-blinded, parallel design study to evaluate the benefits of long-term consumption of two experimental blends of liquid supplements.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04164602 -
The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly
|
||
Completed |
NCT05915338 -
Training on Using ıInsulin in Patients With Type 2 Diabetes
|
||
Not yet recruiting |
NCT04998461 -
Impact of Obesity, Chronic Kidney Disease and Type 2 Diabetes on Human Urinary Stem Cells
|
||
Not yet recruiting |
NCT04880005 -
Digital Individualized and Collaborative Treatment of T2D in General Practice Based on Decision Aid
|
N/A | |
Recruiting |
NCT05365529 -
Time-Restricted Eating for Type II Diabetes: TRE-T2D
|
N/A | |
Recruiting |
NCT03958591 -
Effects of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification
|
Phase 4 | |
Completed |
NCT05284071 -
Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation
|
N/A | |
Recruiting |
NCT05501093 -
Diabetes Reversal and the Subgingival Microbiota
|
||
Active, not recruiting |
NCT05784220 -
The Canadian Diabetes Prevention Program
|
N/A | |
Active, not recruiting |
NCT04286555 -
Dietary Approaches to Stop Hypertension for Diabetes
|
N/A | |
Completed |
NCT05076656 -
Epigenetic and Microbiota Modifications
|
Early Phase 1 | |
Completed |
NCT04423302 -
Effect of Totum-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia (REVERSE-IT)
|
N/A | |
Completed |
NCT05928637 -
A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150
|
Phase 1 | |
Active, not recruiting |
NCT04660630 -
A Real World Research: Comparison of Precision and Experience Therapy for Hypertension, Diabetes or Hyperlipidemias
|
N/A | |
Recruiting |
NCT03435328 -
Hyposalivation Response To Transcutaneous Electrical Nerve Stimulation In Diabetic Type 2 Patients
|
N/A | |
Recruiting |
NCT04447859 -
16-week Flexible vs. 8-week Semaglutide Titration
|
Phase 3 | |
Not yet recruiting |
NCT03968354 -
NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand (RANKL)
|
||
Terminated |
NCT04819256 -
Primary Care Based Integrated Community Care Team Intervention
|
N/A | |
Recruiting |
NCT05629221 -
Organisational Models Supported by Technology for the Management of Diabetic Disease and Its Complications in a Diabetic Clinic Setting. A Randomised Controlled Trial Targeting Type 2 Diabetes Individuals With Non-ideal Glycemic Values
|
N/A |